KWALITY PHARMACEUTICALS
Back to Income Statement
|
KWALITY PHARMACEUTICALS Last 5 Year Revenue History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹307 Cr | ₹251 Cr | ₹456 Cr | ₹262 Cr | ₹139 Cr |
What is the latest Revenue of KWALITY PHARMACEUTICALS ?
Year | Revenue |
---|---|
Mar2024 | ₹307 Cr |
Mar2023 | ₹251 Cr |
Mar2022 | ₹456 Cr |
Mar2021 | ₹262 Cr |
Mar2020 | ₹139 Cr |
How is Revenue of KWALITY PHARMACEUTICALS Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹307 Cr | 22.36 | |
Mar2023 | ₹251 Cr | -44.97 | |
Mar2022 | ₹456 Cr | 74.11 | |
Mar2021 | ₹262 Cr | 88.10 | |
Mar2020 | ₹139 Cr | - |
Compare Revenue of peers of KWALITY PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
KWALITY PHARMACEUTICALS | ₹730.1 Cr | -13.7% | -32.5% | 62.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹407,827.0 Cr | -3.1% | -3.9% | 12.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹157,931.0 Cr | -2.9% | -0.8% | 62.5% | Stock Analytics | |
CIPLA | ₹117,322.0 Cr | 1.1% | 0.3% | 1.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,116.0 Cr | -1.3% | -9.4% | -0.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹94,752.0 Cr | -3.7% | -5.9% | 19.7% | Stock Analytics |
KWALITY PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KWALITY PHARMACEUTICALS | -13.7% |
-32.5% |
62.1% |
SENSEX | -2.9% |
-0.1% |
6.8% |
You may also like the below Video Courses